Preview
Link Preview
PMLive
Amazon’s invasion
Unless you have been blindfolded with your fingers in your ears, you can’t have missed the fuss about Amazon entering the pharma market as a new channel. This is understandable. Jeff Bezos’ organisation is incredibly competitive and the disruption it has caused in every market it has touched is a business phenomenon. To discount the threat of Amazon, even if it hasn’t entered your market yet, would be naïve. But it’s no good just being alarmed. Strategists in the life science sector need to understand the implications of Amazon’s entry. As usual, I take an evolutionary perspective on this. Bear with me while I take a Darwinian detour before returning to the real-world implications of recent events.
Unless you have been blindfolded with your fingers in your ears, you can’t have missed the fuss about Amazon entering the pharma market as a new channel. This is understandable. Jeff Bezos’ organisation is incredibly competitive and the disruption it has caused in every market it has touched is a business phenomenon. To discount the threat of Amazon, even if it hasn’t entered your market yet, would be naïve. But it’s no good just being alarmed. Strategists in the life science sector need to understand the implications of Amazon’s entry. As usual, I take an evolutionary perspective on this. Bear with me while I take a Darwinian detour before returning to the real-world implications of recent events.
Issue #2
This is a part of the article
- dot
- This is not a part of the article, each post by this person contains the same message.
- Declined by admin
- Type of issue
- IV page is missing essential content
- Reported
- Mar 4, 2019